ARCHIVES

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

This article is from The Cancer Letter archive.

Vol. 38 No. 41 | November 1, 2012

Download PDF Visit The Full Archive

Related Articles

NCA Uneasy Over Possible NIH Takeover Of FCRC, But It Won’t Happen

June 13, 1980

SmithKline Seeks FDA Action Against Homeopathic Smoking-Cessation Gum

March 6, 1998

IOM Committee Advises DOD To Fund Grants; Training, Infrastrucure In Breast Cancer; Goals To Raise Number of New Investigators

May 21, 1993

Beyond Planned Parenthood: Attendance Flags at Komen Flagship Race, D.C. Participation Drops by Nearly One-Third

June 8, 2012

UICC Fellowship Program Announced

January 2, 1981

NCI Picks 11 Centers For Chemical Biology Consortium

October 23, 2009